Skip to main content
. 2010 Aug 27;101(12):2629–2636. doi: 10.1111/j.1349-7006.2010.01713.x

Figure 1.

Figure 1

 Expression of CYP2C8, 2C9 and 2J2 and concentrations of epoxyeicosatrienoic acids (EET) in human prostate carcinoma cells. (A) Relative CYP2C8, 2C9 and 2J2 mRNA normalized to HPRT1 mRNA and compared with the level of CYP2C9 mRNA in PC‐3 cells (n = 5). (B) Immunoreactive bands for CYP2C8/9/19, CYP2C8, CYP2C9 and β‐actin. (C) Immunoreactive band intensity of CYP2C8/9/19, 2C8 and 2C9 to the band intensity of β‐actin and normalized to the intensity ratio in PC‐3 cells (n = 3, 4). Concentrations of (D) 11,12‐EET and (E) 14,15‐EET in prostate carcinoma cells normalized to protein content (n = 6).